Medindia LOGIN REGISTER
Medindia
Advertisement

Noted Litigator to Address American Urogynecologic Society Conference

Monday, September 26, 2016 Education News
Advertisement
Sessions Will Review Pros and Cons, Litigation Issues of Transvaginal Mesh

HOUSTON, Sept. 26, 2016 /PRNewswire/ -- Derek H. Potts, founder and national managing partner of Potts Law Firm, will present on the current status of vaginal mesh sling litigation at the prestigious American Urogynecologic Society's PFD Week in Denver, Colorado, Sept. 27-Oct. 1.
Advertisement

Photo - http://photos.prnewswire.com/prnh/20160926/411667

Pelvic Floor Disorders (PFD) Week is the go-to meeting for health care professionals interested in or actively practicing Female Pelvic Medicine and Reconstructive Surgery. Potts' sessions address the claims made by tens of thousands of women who suffer with infections, tissue erosion and organ perforation after receiving a transvaginal mesh implant. These sessions will help physicians better navigate legal issues to provide optimal care and informed consent.  
Advertisement

"Having a plaintiff attorney address a conference of medical professionals is unusual and a testament to the significance of this major health concern for women," said Potts. "I commend the organization for wanting to dive deep into the litigation claims, patient issues and legal rulings that are being reviewed nationwide."

Potts was one of the lawyers who moved to establish the Consolidated Transvaginal Mesh Multi District Litigation in the U.S. District Court for the Southern District of West Virginia. He was appointed by two federal judges overseeing the mesh litigation to coordinate the consolidations on behalf of 100,000 women making claims against the manufacturers of the mesh products. He has successfully resolved tens of thousands of transvaginal mesh claims for his clients.

Transvaginal mesh is a net-like implant used to treat pelvic organ prolapse and stress urinary incontinence in women. The product design and implantation technique can contribute to serious complications, such as erosion and organ perforation.

Potts will participate in two unique sessions to bring a legal perspective to the discussion. One session involves a panel presentation on the current status of vaginal mesh and sling litigation, the reasons for successful verdicts against mesh manufacturers, the impact on available mesh products, changes to the FDA clearance process and reclassification, and the impact on physician care and informed consent. 

The second session will involve a brief mock trial that will involve experienced medical experts. As part of this process, discussions will take place regarding the defects of vaginal mesh design, manufacturer's failure-to-warn claims, mesh degradation and causation of patient injuries.

Widely recognized for his expertise in complex litigation and trials, Potts has obtained record-setting verdicts and settlements on behalf of clients in state and federal courts across the country. He also regularly speaks and lectures to lawyers around the country on topics ranging from trial advocacy to handling complex mass torts matters.

About Potts Law Firm

Potts Law Firm diligently pursues a variety of personal injury claims and mass tort matters, from complex pharmaceutical cases to challenging product liability claims.  The firm's team of highly competent attorneys have experience in many different areas of personal injury law. Believing that every detail of a case matters, firm attorneys work tirelessly to pursue just compensation, regardless of the obstacles faced. For more information, visit www.potts-law.com

For more information contact:

Steve Stasny832-838-4553Email

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/noted-litigator-to-address-american-urogynecologic-society-conference-300333894.html

SOURCE Potts Law Firm

Sponsored Post and Backlink Submission


Latest Press Release on Education News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close